CPIX

Cumberland Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality1/10
  • Growth↑ 5/10
  • Value↓ 1/10
Cumberland Pharmaceuticals sales and earnings growth
CPIX Growth
Neutral
  • Revenue Y/Y↓ -4.66%
  • EPS Y/Y↓ -96.00%
  • FCF Y/Y↓ -100.72%
Cumberland Pharmaceuticals gross and profit margin trends
CPIX Profitability
Low
  • Gross margin ↑ 82.90%
  • EPS margin↓ -17.60%
  • ROIC 5Y↓ -16.23%
Cumberland Pharmaceuticals net debt vs free cash flow
CPIX Risk
Great
  • Debt / Equity↓ 0.7
  • Debt / FCF↑ 120.6
  • Interest coverage↓ -16.6

Cumberland Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Drug Manufacturers - Specialty & Generic stocks